Abstract: A Streptococcus suis (S. suis) vaccine is provided. For the S. suis vaccine, an antigen is a protein with an amino acid sequence shown in SEQ ID NO: 2. A preparation method of the S. suis vaccine is provided, including the following steps: mixing a white oil and aluminum stearate to obtain a white oil adjuvant; adding poly sorbate 80 to an aqueous solution of the protein with the amino acid sequence shown in SEQ ID NO: 2, and thoroughly mixing to obtain an antigen solution; and mixing the antigen solution with the white oil adjuvant according to a volume ratio of (0.5-1.5):2, and emulsifying to obtain the S. suis vaccine. An animal immunized with the S. suis vaccine of the present disclosure can effectively resist the attack of S. suis serotype 2, 3, and 31, with a vaccine protection rate as high as 100%.

Abstract: System and method for processing an analog signal. For example, a demodulator for processing an analog signal includes one or more analog-to-digital converters configured to receive an analog signal and generate a digital signal based at least in part on the analog signal, and a correlator coupled to the one or more analog-to-digital converters and configured to generate a stream of correlation results including a first plurality of correlation results, a second plurality of correlation results, and a third plurality of correlation results. The first plurality of correlation results is different from the second plurality of correlation results by at least one correlation result, and the second plurality of correlation results is different from the third plurality of correlation results by at least another correlation result.

Abstract: A method and system for in operando, in situ, and real-time monitoring the state of an electrochemical device, e.g. battery, is provided, which is by means of an optical fiber probe inside the electrochemical device. The method includes: shedding an input light into the optical fiber probe and detecting an output light transmitted therefrom; and determining state of health of the electrochemical device based on the output light. The determination step can be based on a change of the refractive index or of the cladding mode or the surface plasmon resonance, all derived from the output light, in the instant state compared to a prior state. The method can simultaneously detect other parameters including state of charge, temperature, pressure, strain, displacement, vibration, or gas release inside the electrochemical device. With a core mode for correction, the determination of these parameters can also realize a high accuracy.

Abstract: The invention relates to a method for in-life testing of the formation of the solid electrolyte interface layer of a battery cell, comprising the following steps: sensing the temperature within the battery cell, recording a first set of temperature (T) and/or pressure data related to the temperature variation (?T) and/or pressure variation within the battery cell over a first charge of the battery cell, and determining a positive or negative datum relating to the formation of solid electrolyte interface layer of the battery cell according to said first set of temperature and/or pressure data

Abstract: A method for selecting between a first battery cell and a second battery cells includes sensing a total generated heat flow rate emitted by the first battery cell and the second battery cells. The method further includes recording, for the first and second battery cells, first and second sets of heat flow rate data related to the total generated heat flow rate emitted by the first and second battery cells, respectively, over their first charge. The method further includes comparing the first set of heat flow rate data with the second set of heat flow rate data, and selecting one of the first or second battery cells according to the comparison between the first set of heat flow rate data with the second set of heat flow rate data.

Abstract: System and method for processing an analog signal. For example, a demodulator for processing an analog signal includes one or more analog-to-digital converters configured to receive an analog signal and generate a digital signal based at least in part on the analog signal, and a correlator coupled to the one or more analog-to-digital converters and configured to generate a stream of correlation results including a first plurality of correlation results, a second plurality of correlation results, and a third plurality of correlation results. The first plurality of correlation results is different from the second plurality of correlation results by at least one correlation result, and the second plurality of correlation results is different from the third plurality of correlation results by at least another correlation result.

Abstract: Provided herein is an electrode material containing metallic sodium and at least one tin-sodium binary alloy useful in the fabrication of batteries and methods of preparation and use thereof.

Abstract: System and method for processing an analog signal. For example, a demodulator for processing an analog signal includes one or more analog-to-digital converters configured to receive an analog signal and generate a digital signal based at least in part on the analog signal, and a correlator coupled to the one or more analog-to-digital converters and configured to generate a stream of correlation results including a first plurality of correlation results, a second plurality of correlation results, and a third plurality of correlation results. The first plurality of correlation results is different from the second plurality of correlation results by at least one correlation result, and the second plurality of correlation results is different from the third plurality of correlation results by at least another correlation result.

Abstract: Provided herein is an electrode material containing metallic sodium and at least one tin-sodium binary alloy useful in the fabrication of batteries and methods of preparation and use thereof.

Abstract: System and method for processing an analog signal. For example, a demodulator for processing an analog signal includes one or more analog-to-digital converters configured to receive an analog signal and generate a digital signal based at least in part on the analog signal, and a correlator coupled to the one or more analog-to-digital converters and configured to generate a stream of correlation results including a first plurality of correlation results, a second plurality of correlation results, and a third plurality of correlation results. The first plurality of correlation results is different from the second plurality of correlation results by at least one correlation result, and the second plurality of correlation results is different from the third plurality of correlation results by at least another correlation result.

Abstract: The present invention provides chemokine-like factor (CKLF) polypeptides with chemotactic and hematopoietic stimulating activities and polynucleotides encoding such polypeptides. Additionally, a method for producing such CKLF polypeptides by recombinant techniques is provided. Also provided are the antibodies and antagonists against such polypeptides. The present invention further disclose a drug compound comprising a therapeutically effective amount of such CKLF polypeptides as well as pharmaceutically acceptable excipients and carriers. Also disclosed are the uses of such CKLF polypeptides and polynucleotides in diagnostics or therapeutics to treat immunodeficiency, hematopoietic diseases and primary tumors.

Abstract: The present invention provides chemokine-like factor (CKLF) polypeptides with chemotactic and hematopoietic stimulating activities and polynucleotides encoding such polypeptides. Additionally, a method for producing such CKLF polypeptides by recombinant techniques is provided. Also provided are the antibodies and antagonists against such polypeptides. The present invention further disclose a drug compound comprising a therapeutically effective amount of such CKLF polypeptides as well as pharmaceutically acceptable excipients and carriers. Also disclosed are the uses of such CKLF polypeptides and polynucleotides in diagnostics or therapeutics to treat immunodeficiency, hematopoietic diseases and primary tumors.

Abstract: The present invention provides chemokine-like factor (CKLF) polypeptides with chemotactic and hematopoietic stimulating activities and polynucleotides encoding such polypeptides. Additionally, a method for producing such CKLF polypeptides by recombinant techniques is provided. Also provided are the antibodies and antagonists against such polypeptides. The present invention further disclose a drug compound comprising a therapeutically effective amount of such CKLF polypeptides as well as pharmaceutically acceptable excipients and carriers. Also disclosed are the uses of such CKLF polypeptides and polynucleotides in diagnostics or therapeutics to treat immunodeficiency, hematopoietic diseases and primary tumors.

Abstract: The present invention provides chemokine-like factor (CKLF) polypeptides with chemotactic and hematopoietic stimulating activities and polynucleotides encoding such polypeptides. Additionally, a method for producing such CKLF polypeptides by recombinant techniques is provided. Also provided are the antibodies and antagonists against such polypeptides. The present invention further disclose a drug compound comprising a therapeutically effective amount of such CKLF polypeptides as well as pharmaceutically acceptable excipients and carriers. Also disclosed are the uses of such CKLF polypeptides and polynucleotides in diagnostics or therapeutics to treat immunodeficiency, hematopoietic diseases and primary tumors.